Fact CheckerSign in

NCT07279948Not yet recruiting

Lung Cancer Screening Implementation Project in the Brazilian Public Health Care System (LUSIP)

Source: ClinicalTrials.gov · Last updated 11 Sept 2026

Brief summary (registry, in English)

A prospective, longitudinal, single-arm interventional study of lung cancer screening.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
477 (estimated)
First submitted
1 Dec 2025
Start date
30 Oct 2026
Primary completion date
31 Jan 2027
Lead sponsor
AstraZeneca
Diseases
Lung cancer
NCT number
NCT07279948

What you commit to

  • Study type: Observational
  • Planned participants: 477
  • From 30 Oct 2026 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • In order, to be exclude for the study, patients must at least one of the following exclusion criteria:
    • Contraindications to the screening examination: (claustrophobic or weighing more than 130 kgs).
    • Inability to climb 3 stair steps non-stop (36 steps).
    • Disabling dyspnea
    • Symptomatic (with signs and symptoms suspicious of breast cancer lung, namely):
    • pleuritic chest pain
    • rapidly progressive dyspnea of recent onset
    • hemoptysis
    • unexplained hoarseness, lasting more than 1 month.
    • bone pain
    • supraclavicular lymphadenopathy or cervical lymphadenopathy persistent
    • unexplained weight loss of 5% or more of weight in less than 6 months
    • Previous history of malignant neoplasm (excluding non-melanoma skin cancer) diagnosed less than 10 years before the date of the interview;
    • Patients with diagnostic of severe psychiatric disease
    • Immunosuppressed by illness or drugs.
    • Subjected to anterior lung resection even when determined due to an etiology other than malignant neoplasia.
    • Person with a serious terminal illness that contraindicates curative lung surgery.

Who the study is looking for

  • In order, to be eligible for the study, patients must fulfill all the following inclusion criteria:
  • Age between ≥50 and ≤80 years.
  • Be a current smoker or have quit 15 years ago or less.
  • Have participated or are currently participating in smoking cessation program.
  • Lifetime smoking exposure equal to or greater than 20 pack-year.
  • Provided signed informed consent (ICF)

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
-
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.